Pilot trial of amlodipine/celecoxib [KIT-302] in patients with hypertension

Trial Profile

Pilot trial of amlodipine/celecoxib [KIT-302] in patients with hypertension

Phase of Trial: Phase I

Latest Information Update: 10 May 2016

At a glance

  • Drugs Amlodipine/celecoxib (Primary) ; Amlodipine; Celecoxib
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 May 2016 According to Kitov media release, company will submit NDA to the FDA at the end of this year and anticipated marketing approval in 2017. Results from this study has fulfilled the FDA standard for demonstrating bioequivalence under both fed and fasted conditions.
    • 10 May 2016 Results published in Kitov media release.
    • 10 May 2016 Status changed from planning to completed, as per Kitov media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top